28 results
8-K
EX-99.4
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
of Elicio’s Business—Government Regulation and Product Approval—FDA Regulation—Fraud and Abuse, Data Privacy and Security, and Transparency Laws … to data privacy and security and changes in such laws, regulations, policies and contractual obligations could adversely affect its business.
Elicio
8-K
EX-99.3
s2qhpy7id i272v
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
424B3
8epuitee0twc2vgwdmt
28 Apr 23
Prospectus supplement
4:07pm
S-4/A
EX-10.27
wtpbh masjowtfhi6ux
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.28
spb27ne
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
0x83dt630p
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
10-Q
hork qkh20zx
17 May 21
Quarterly report
6:03am
10-K
islhfr 38l4
30 Mar 21
Annual report
5:00pm
424B4
32gxooety
5 Feb 21
Prospectus supplement with pricing info
5:12pm